Work

Dianhydrogalactitol in bevacizumab-refractory GBM: Further analysis of a phase 1-2 trial.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.2061

Authors: Kent C. Shih, Manish R. Patel, Nicholas A. Butowski, Gerald Steven Falchook, Sani Haider Kizilbash, Suzanne Fields Jones, Jeffrey A. Bacha, Dennis Brown, Richard Stephen Schwartz, Sarath Kanekal, John C.I. Constant, Howard A. Burris

Institutions: Sarah Cannon, Tennessee Oncology, University of California, San Francisco, Mayo Clinic, Delmar (Canada), PRA Health Sciences

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2889754233

Cites:

Cited by: 3

Related to: 10